Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
myeloma
Pharma
FDA advisors back Darzalex as treatment for early myeloma
Despite doubts from the FDA, favorable findings across multiple analyses persuaded most panelists of Darzalex's profile in smoldering myeloma.
Angus Liu
May 21, 2025 8:52am
Legend Biotech looks to raise $350M amid CAR-T rollout
Jul 26, 2022 11:27am
BMS-Eisai, China price cuts, AZ-Hutchmed—Fierce Pharma Asia
Jun 25, 2021 10:50am
Karyopharm snags DLBCL nod for Xpovio
Jun 23, 2020 10:40am
J&J's Darzalex branches out beyond myeloma with amyloidosis win
Jun 13, 2020 2:30am
